| |
|
The Future Of Biosecurity
|
| With Amit Gupta (Founder, Catalyze), Akhila Kosaraju (CEO, Phare Bio), Charlie Petty (Co-Head, Intercept), Spencer Weiss (Technical Lead of Federal Health, Palantir). |
|
Jul 08 (Wed) @ 05:30 PM
FREE
| | Venue, To Be Announced
|
|
|
|
|
| |
| Register |
|
|
| |
Biosecurity work spans preventing, defending against, & recovering from biological threats to safeguard public health, ecosystems, & societal stability. It's gaining urgency as recent outbreaks strain detection & response & as AI lowers the barrier to engineered bio-threats.
Software is becoming central to the defense, & the technology industry is moving in with the formation of dozens of new startups & thesis-driven funds tackling biosecurity threats. We're bringing together leaders to show how these solutions get built & scaled.
We'll discuss how software protects against outbreaks today, how AI reshapes the future threat landscape, how it can speed the deployment of monitoring systems & countermeasures, & what it would take to end all respiratory disease.
Speakers include:
Spencer Weiss is the Technical Lead of Federal Health at Palantir. He's led projects that operate the US government's public health, bioscience research, & healthcare delivery. He's previously worked at startups, & is a graduate of the Jerome Fisher Program in Management & Technology at the University
of Pennsylvania.
Dr. Akhila Kosaraju is the CEO & co-founder of Phare Bio, a biotech social venture pioneering the use of generative AI to discover novel antibiotics in partnership with the Collins Lab at MIT. Phare launched with support from TED's Audacious Project, has been awarded $27M from ARPA-H, & recently received support from Google.org's Generative AI Accelerator. A physician & biotech executive, Dr. Kosaraju has led efforts across startups, government, & global health. She previously served as founding CEO of Variant Bio, an executive at SIGA Technologies, & a White House appointee in the Pentagon helping to oversee the Military Health System. She is a Member of the Council on Foreign Relations, co-founder of the Alliance to End Biological Threats, & a Lecturer at Stanford. She earned her M.D. from Columbia & her B.A. from Stanford.
Charlie Petty is the co-head of Intercept & a long time investor in global public health technologies. He previously held leadership & investing roles at GHIC, Adjuvant Capital & the Global Health Investment Fund. Prior public health investments include Curevo (Eli Lilly), Vaccine Company (Eli Lilly), Alydia Health (Merck), Iantech (Carl Zeiss), Minervax, Monod Bio, Eubiologics, Terrestrial Bio, Centivax, Excision Biosciences, Codagenix, & Vitrivax.
About the moderator:
Amit Gupta is a member of SPC & the co-founder of Catalyze, an AI-powered platform for discovering, funding, & executing frontier science. Catalyze acts as a coordination layer across the research funding lifecycle, giving researchers visibility for their work, helping funders deploy capital with confidence, & reducing the friction between the two. The team works directly with institutions, foundations, & government agencies to build custom R&D infrastructure & AI tooling. Before Catalyze, Amit held multiple roles as a biotech operator & investor.
About South Park Commons (SPC)
SPC is a technical community & venture fund dedicated to helping founders, researchers, & technologists figure out what to work on next-what we call the -1 to 0 stage of your career. We believe this is best accomplished in the most talent-dense community possible. If that's you, apply for SPC membership.
|
|
|
|
|
|
|
|
